Effects of Altitude on Diabetes Rates Explained by New Research

It’s been observed that diabetes rates are generally lower in high-altitude regions, but the reasons behind this trend have been somewhat elusive until now. Recent research involving mice suggests that red blood cells might play a crucial role. These cells could potentially lower blood sugar levels by converting glucose into a compound that aids in releasing oxygen to body tissues.

If these findings hold true for humans, they could indicate new avenues for the development of diabetes medications that mimic this process.

Understanding Blood Sugar Levels at High Altitudes

People residing at high altitudes, such as in the Andes and Himalayas, often experience lower diabetes rates. Yet, the connection wasn’t entirely clear. A study from 2023 observed similar results in mice: when subjected to environments with low oxygen, the mice developed a condition called “hypoxia,” which significantly lowered their blood glucose levels.

However, the drop in glucose wasn’t fully accounted for by how much the muscle and organs absorbed. This left scientists questioning where all that glucose was disappearing to.

Investigating Red Blood Cells in Controlled Settings

To explore the role of red blood cells in glucose regulation, researchers placed mice in low-oxygen chambers, simulating high-altitude conditions. A control group was kept in rooms with normal oxygen levels. After several weeks, both groups received glucose injections, and their blood sugar levels were monitored. The mice exposed to low oxygen showed a markedly smaller increase in blood sugar, implying a quicker clearance of glucose from their system. This effect lingered even after returning to normal oxygen levels, suggesting a long-term metabolic change.

The scientists used imaging scans to determine how much glucose was being absorbed by critical organs. Still, a significant amount of glucose remained unaccounted for, prompting an investigation into the blood cells’ glucose consumption.

To delve deeper, the researchers manipulated the number of red blood cells in the oxygen-deprived mice. By periodically withdrawing blood, they maintained normal red-blood-cell levels, which negated the glucose-lowering effects of hypoxia. Conversely, transfusing red blood cells into the mice in normal air led to diminished glucose levels, indicating that red blood cell quantities significantly impacted blood sugar.

Next, by injecting the mice with labeled glucose, the researchers tracked how it was processed. Notably, red blood cells from oxygen-deprived mice absorbed considerably more glucose than those from the control group. These cells rapidly converted glucose into a molecule that binds to hemoglobin, thereby enhancing oxygen release in low-oxygen conditions.

Adaptations of Red Blood Cells in Low-Oxygen Conditions

Further studies revealed that red blood cells produced in low-oxygen environments had elevated levels of a protein named GLUT1, essential for glucose entry into cells. These red blood cells exhibited nearly double the GLUT1 and absorbed about three times the glucose compared to their normal counterparts. Labeling existing red blood cells confirmed that only newly formed cells showed these adaptations.

Experts noted that beyond merely increasing red blood cell counts, the structural changes in these cells enhanced their sugar consumption abilities under low-oxygen conditions. This was supported by research from other scientists who indicated that the body naturally ramps up red blood cells in thin air to facilitate better oxygen transport.

Potential for New Diabetes Treatments?

In a separate experiment, researchers treated mice with an experimental compound named HypoxyStat, which promotes stronger hemoglobin binding to oxygen, mimicking hypoxia. This approach could potentially increase red blood cell count and aid in blood glucose regulation. However, much more research is necessary before considering clinical trials for humans.

While blood transfusions may not be a feasible treatment for diabetes, the findings raise intriguing possibilities. For instance, developing engineered red blood cells designed to function more efficiently as glucose sinks could represent a paradigm shift in diabetes treatment. Jain expressed optimism, highlighting the opportunity to reconsider diabetes therapies fundamentally.